News

A Cambridge biotech has taken over development of a Roche rare disease drug, Cue Biopharma signed a deal with Boehringer ...
Elevation Oncology has become the second biotech this week to face calls from an activist investor to wind down the company.
After mass layoffs, the FDA has started missing certain deadlines, pushing one biopharma to delay a phase 3 trial and ...
“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...
With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
The Food and Drug Administration on Thursday approved a core component of a brain implant made by Precision Neuroscience, a ...
The budget proposes a massive $20 billion cut for the NIH in 2026 — roughly a 40% reduction — and a sweeping consolidation, from 27 institutes and centers to just eight. Any final budget plan will ...
The layoffs come as the biotech industry struggles. The post Mass. biotech company cuts 90% of workforce appeared first on Boston.com.
The Summer Fridays Jet Lag Mask has been a viral cult hit since its launch. Now, meet the Jet Lag Eye Patches, a set of ...
Donald Trump's healthcare revamp, emphasizing generics and biosimilars, could boost Indian drug makers, who already supply 40 ...
Loyal, a Bay Area biotech company has developed a new pill that could extend a dog’s life. After one year of the ...